Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Hapgood JP, Kaushic C, Hel Z.

Endocr Rev. 2018 Feb 1;39(1):36-78. doi: 10.1210/er.2017-00103.


Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+‚ÄČT cells.

Shen Z, Rodriguez-Garcia M, Patel MV, Bodwell J, Kashuba ADM, Wira CR.

Sci Rep. 2017 Dec 18;7(1):17697. doi: 10.1038/s41598-017-18078-3.


Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Polis CB, Achilles SL, Hel Z, Hapgood JP.

Contraception. 2018 Mar;97(3):191-197. doi: 10.1016/j.contraception.2017.12.003. Epub 2017 Dec 11. No abstract available.


Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women.

Thurman AR, Yousefieh N, Chandra N, Kimble T, Asin S, Rollenhagen C, Anderson SM, Herold BC, Freiermuth JL, Starkman BS, Mesquita PMM, Richardson-Harman N, Cunningham T, Hillier S, Rabe L, Schwartz JL, Doncel GF.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):807-819. doi: 10.1089/AID.2016.0320. Epub 2017 May 16.


Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.

Nanda K, Callahan R, Taylor D, Wang M, Agot K, Jenkins D, Van Damme L, Dorflinger L; FEM-PrEP Study Group.

Contraception. 2016 Jul;94(1):40-7. doi: 10.1016/j.contraception.2016.03.003. Epub 2016 Mar 10.


Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.

Huijbregts RP, Michel KG, Hel Z.

Contraception. 2014 Aug;90(2):123-9. doi: 10.1016/j.contraception.2014.02.006. Epub 2014 Feb 26. Erratum in: Contraception. 2016 Nov;94(5):578.


Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.

Beasley A, White KO, Cremers S, Westhoff C.

Contraception. 2014 May;89(5):352-6. doi: 10.1016/j.contraception.2014.01.026. Epub 2014 Feb 7.


A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females.

Bonny AE, Lange HL, Rogers LK, Gothard DM, Reed MD.

Contraception. 2014 May;89(5):357-60. doi: 10.1016/j.contraception.2014.01.017. Epub 2014 Feb 1.


Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Thurman AR, Clark MR, Hurlburt JA, Doncel GF.

Int J Womens Health. 2013 Oct 21;5:695-708. doi: 10.2147/IJWH.S34030. Review.


The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Kleynhans L, Du Plessis N, Allie N, Jacobs M, Kidd M, van Helden PD, Walzl G, Ronacher K.

Infect Immun. 2013 Apr;81(4):1234-44. doi: 10.1128/IAI.01189-12. Epub 2013 Feb 4.


Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

Huijbregts RP, Helton ES, Michel KG, Sabbaj S, Richter HE, Goepfert PA, Hel Z.

Endocrinology. 2013 Mar;154(3):1282-95. doi: 10.1210/en.2012-1850. Epub 2013 Jan 25.


Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection.

Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Harvey SA, Terry-Allison T, St Leger AJ, Thomson AW, Cherpes TL.

J Immunol. 2012 Oct 1;189(7):3449-61. Epub 2012 Aug 31.


Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Cancer Res. 2012 Apr 15;72(8):2028-35. doi: 10.1158/0008-5472.CAN-11-4064. Epub 2012 Feb 27.


Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users.

Kleynhans L, Du Plessis N, Black GF, Loxton AG, Kidd M, van Helden PD, Walzl G, Ronacher K.

PLoS One. 2011;6(9):e24639. doi: 10.1371/journal.pone.0024639. Epub 2011 Sep 8.


Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.

Beksinska ME, Kleinschmidt I, Smit JA, Farley TM.

Contraception. 2009 May;79(5):345-9. doi: 10.1016/j.contraception.2008.11.009. Epub 2009 Jan 17.


Effect of depot medroxyprogesterone acetate on glucose tolerance in generalized lipodystrophy.

Yauger BJ, Gorden P, Park J, Cochran E, Stratton P.

Obstet Gynecol. 2008 Aug;112(2 Pt 2):445-7. doi: 10.1097/AOG.0b013e3181662d17.


Facts about injectable contraceptives: memorandum from a WHO meeting.

[No authors listed]

Bull World Health Organ. 1982;60(2):199-210.

Supplemental Content

Support Center